
SGBI
Healthcare · Drug Manufacturers - Specialty & Generic · $314,853 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2017
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 6, 2025 | Time not confirmed | — | 0.00 | — |
| Feb 13, 2025 | Time not confirmed | — | 0.00 | — |
| Nov 10, 2022 | Time not confirmed | — | 0.00 | — |
| Sep 28, 2022 | Time not confirmed | — | 0.00 | — |
| May 16, 2022 | Time not confirmed | — | -0.00 | — |
| Feb 11, 2022 | Time not confirmed | — | 0.00 | — |
| Nov 12, 2021 | Time not confirmed | — | -0.00 | — |
| Sep 28, 2021 | Time not confirmed | — | -0.00 | — |
| May 7, 2021 | Time not confirmed | — | -0.00 | — |
| Feb 9, 2021 | Time not confirmed | — | -0.00 | — |
| Nov 13, 2020 | Time not confirmed | — | -0.00 | — |
| Sep 30, 2020 | Time not confirmed | — | -0.00 | — |
| May 14, 2020 | Time not confirmed | — | -0.00 | — |
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray…
| Time not confirmed |
| — |
| -0.00 |
| — |
| Oct 8, 2019 | Time not confirmed | — | -0.00 | — |
| Sep 30, 2019 | Time not confirmed | — | -0.00 | — |
| May 13, 2019 | Time not confirmed | — | -0.00 | — |
| Feb 13, 2019 | Time not confirmed | — | -0.00 | — |
| Nov 13, 2018 | Time not confirmed | — | -0.00 | — |
| Sep 28, 2018 | Time not confirmed | — | -0.00 | — |
| May 3, 2018 | Time not confirmed | — | -0.00 | — |
| Mar 31, 2018 | Time not confirmed | — | -0.00 | — |